Evidence map›Paper›PMID 20093396›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2010

Up-regulation of the RhoA/Rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice.

Fernanda B M Priviero, Li-Ming Jin, Zhekang Ying, Cleber E Teixeira, R Clinton Webb

Erratum issuedOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Liraglutide Ameliorates Erectile DysfunctionFrontiers in pharmacology · 2020
    Article
  5. Rho-Kinase II Inhibitory Potential ofEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Fernanda B M PrivieroRua José Aparecido Pavan, 190, 13086-080, Campinas-SP, Brazil. fernanda.bmp@gmail.com
Li-Ming Jin
Zhekang Ying
Cleber E Teixeira
R Clinton Webb
Augusta University · USUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

Vascular Rho-kinase Signaling in Angiotensin II hypertenP01HL074167 · NHLBI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI WEBB, R CLINTON · 2004 to 2008
$10.5M
Nitric Oxide Inhibits RhoA/Rho-kinase in Penile ErectionR01HL071138 · NHLBI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI WEBB, R CLINTON · 2003 to 2011
$2.9M
TNF-alpha: a key player in erectile (dys)functionR01DK083685 · NIDDK · AUGUSTA UNIVERSITY · PI WEBB, R CLINTON · 2009 to 2012
$1.4M
NHLBI NIH HHS HL71138NHLBI NIH HHS HL74167NHLBI NIH HHS P01 HL074167NHLBI NIH HHS R01 HL071138NIDDK NIH HHS R01 DK083685
6 · The paper itself

Abstract

We tested the hypothesis that the basal release of nitric oxide (NO) from endothelial cells modulates contractile activity in the corpus cavernosum (CC) via inhibition of the RhoA/Rho-kinase signaling pathway. Cavernosal strips from wild-type (WT), endothelial nitric-oxide synthase knockout [eNOS(-/-)], and neuronal nitric-oxide synthase knockout [nNOS(-/-)] mice were mounted in myographs, and isometric force was recorded. mRNA and protein expression of key molecules in the RhoA/Rho-kinase pathway were analyzed by real-time polymerase chain reaction and Western blot, respectively. The cGMP levels were determined. The Rho-kinase inhibitors (R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide (Y-27632) and (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl] homopiperazine (H-1152) reduced cavernosal contractions evoked by phenylephrine or electrical field stimulation (EFS) in a concentration-dependent manner, although this inhibition was less effective in tissues from eNOS(-/-) mice. Y-27632 enhanced relaxations induced by sodium nitroprusside, EFS, and NO (administered as acidified NaNO2) without affecting the cGMP content of the cavernosal strips. This enhancement was less prominent in CC from eNOS(-/-). The protein expression of RhoA, Rho-guanine dissociation inhibitor, and Rho-kinase beta did not differ among the strains. However, in eNOS(-/-) CC, the protein expression of Rho-kinase alpha and both mRNA and protein expression of p115-Rho-associated guanine exchange factor (RhoGEF), PDZ-RhoGEF, and leukemia-associated RhoGEF were up-regulated. Phosphorylation of MYPT1 at Thr696 was higher in tissues from eNOS(-/-) mice. A high concentration of Y-27632 significantly enhanced NO release in CC stimulated by EFS. These results suggest a basal release of NO from endothelial cells, which inhibits contractions mediated by the RhoA/Rho-kinase pathway and modulates the expression of proteins related to this pathway in mouse CC. It indicates that endothelial integrity is essential to the maintenance of erectile function.

Indexed as

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAmidesAnimalsCyclic GMPEndothelium, VascularIn Vitro TechniquesMaleMiceMice, Inbred C57BLMice, KnockoutMuscle ContractionMuscle RelaxationMuscle, SmoothNitric OxideNitric Oxide Synthase Type INitric Oxide Synthase Type III1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazineAmidesCyclic GMPNitric OxideNitric Oxide Synthase Type INitric Oxide Synthase Type IIIPyridinesrhoA GTP-Binding ProteinRhoA protein, mouserho-Associated Kinasesrho GTP-Binding ProteinsY 27632

Identifiers

PMID20093396
PMCPMC2846021
OpenAlexW2102565511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.